4DMT In The Media

4D Molecular Therapeutics Profiled in BioCentury

BioCentury, a leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government, has published an Emerging Company Profile on 4D Molecular Therapeutics. Co-founders David Schaffer and David Kirn discuss AAV gene therapy, the ...

4DMT Featured in Biotech Documentary

French film company, LaBiotech Tour, recently featured 4D Molecular Therapeutics in their documentary on Bay Area biotech companies. LaBiotech Tour is the first World Tour of Biotech ecosystems, showcasing companies from India to Germany to Ireland. LaBiotech selected 4DMT to ...

Genes Get in Your Eye

Using mouse eyes as a setting for directed evolution, scientists have created a new version of the gene therapy vector adeno-associated virus (AAV) that can deliver genes deep into the retina, according to a paper published online today (June 12) ...